Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.61% | 25.61% | 24.31% | 24.31% | -2.01% |
| Total Depreciation and Amortization | -41.98% | -41.98% | 0.60% | 0.60% | -51.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.65% | 149.65% | -16.30% | -16.30% | 987.13% |
| Change in Net Operating Assets | -106.88% | -106.88% | -117.00% | -117.00% | -256.44% |
| Cash from Operations | 51.40% | 51.40% | 20.00% | 20.00% | 1.35% |
| Capital Expenditure | -100.00% | -100.00% | 99.00% | 99.00% | 104.88% |
| Sale of Property, Plant, and Equipment | -23.93% | -23.93% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -500.00% | -500.00% | -50.00% | -50.00% | 175.00% |
| Cash from Investing | -362.49% | -362.49% | -7.28% | -7.28% | 142.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -79.06% | -79.06% | 7.99% | 7.99% | 83.09% |
| Issuance of Common Stock | -64.42% | -64.42% | 586.10% | 586.10% | 47.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -71.29% | -71.29% | 4.86% | 4.86% | 105.43% |
| Foreign Exchange rate Adjustments | -232.29% | -232.29% | 58.48% | 58.48% | 98.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.44% | -119.44% | 29.03% | 29.03% | 216.87% |